The pharmaceutical industry faces a pressing challenge: striking the optimal balance between accelerated drug development and environmentally responsible practices. While the need for swift advancements to address global health challenges is undeniable, it's crucial to mitigate the industry's carbon emissions. This delicate balance demands here a c